This study retrospectively analysed the emergence of multidrug-resistant Salmonella enterica in a level IV hospital in Lima, Peru. A total of 64 S. enterica from January 2009 to June 2010 (Period 1, 24 isolates) and January 2012 to December 2014 (Period 2, 40 isolates) were included. Some 25 were from non-hospitalized and 39 from hospitalized patients. Antimicrobial susceptibility to 15 antimicrobial agents was established by automated methods. Most of the isolates were from blood (46.9%), urine (21.9%) and faeces (14.1%). There was a reduction in blood isolates in Period 2, while all the faecal isolates were from this period. In Period 1, only 3/24 (12.5%) isolates showed antibiotic resistance, whereas 25/39 isolates (64.1%) from Period 2 were antibiotic-resistant, with multidrug-resistant and extensively drug-resistant rates of 17.9% and 20.5%, respectively. Multidrug-resistant/extensively drug-resistant Salmonella isolates were introduced in the hospital in 2013, with Salmonella recovered from faeces from non-hospitalized patients suggested an increase in community-acquired multidrug-resistant/extensively drug-resistant Salmonella infections.
CabreraRRuizJMarcoF, et al.Mechanism of resistance to several antimicrobial agents in Salmonella clinical isolates causing of traveler's diarrhea. Antimicrob Agents Chemother2004; 48: 3934–3939.
2.
CrumpJASjölund-KarlssonMGordonMA, et al.Epidemiology, clinical presentation, laboratory diagnosis, antimicrobial resistance, and antimicrobial management of invasive Salmonella infections. Clin Microbiol Rev2015; 28: 901–937.
3.
MandomandoIMBassatQSigauqueB, et al.Invasive Salmonella infections among children from rural Mozambique, 2001–2014. Clin Infect Dis.2015; 61: S339–S345.
4.
QureshiSNaveedABYousafzaiMT, et al.Response of extensively drug resistant Salmonella typhi to treatment with meropenem and azithromycin, in Pakistan. PLoS Negl Trop Dis2020; 14: e0008682.
5.
O’ReganEQuinnTFryeJG, et al.Fitness costs and stability of a high-level ciprofloxacin resistance phenotype in Salmonella enterica serotype enteritidis: reduced infectivity associated with decreased expression of Salmonella pathogenicity island 1 genes. Antimicrob Agents Chemother2010; 54: 367–374.
6.
de ToroMRojo-BezaresBVinuéL, et al.In vivo selection of aac(6’)-Ib-cr and mutations in the gyrA gene in a clinical qnrS1-positive Salmonella enterica serovar Typhimurium DT104B strain recovered after fluoroquinolone treatment. J Antimicrob Chemother2010; 65: 1945–1949.
7.
DongNLiYZhaoJ, et al.The phenotypic and molecular characteristics of antimicrobial resistance of Salmonella enterica subsp. enterica serovar Typhimurium in Henan province, China. BMC Infect Dis2020; 20: 511.
8.
HawkeyJLe HelloSDoubletB, et al.Global phylogenomics of multidrug-resistant Salmonella enterica serotype Kentucky ST198. Microb Genom2019; 5: e000269.
9.
GrandaARiverosMMartínez-PucholS, et al.Presence of extended-spectrum β-lactamase, CTX-M-65, in Salmonella enterica serovar Infantis isolated from children with diarrhea in Lima, Peru. J Pediatr Infect Dis.2019; 14: 194–200.
10.
Maguiña-MolinaCPonsMJBeltranM, et al.Multidrug-resistant Salmonella enterica isolated in paca (Cuniculus paca) carcasses from the belen market, iquitos - Peru. Foodborne Pathog Dis2021; 18: 131–138.
11.
Martinez-PucholSRiverosMRuidiasK, et al.Dissemination of a multidrug resistant CTX-M-65 producer Salmonella enterica serovar Infantis clone between marketed chicken meat and children. Int J Food Microbiol2021; 344: 109109.
12.
NadimpalliMFabreLYithV, et al.CTX-M-55-type ESBL-producing Salmonella enterica are emerging among retail meats in Phnom Penh, Cambodia. J Antimicrob Chemother2019; 74: 342–348.
13.
Pérez-MorenoMOPicó-PlanaEde ToroM, et al.β-Lactamases, transferable quinolone resistance determinants, and class 1 integron-mediated antimicrobial resistance in human clinical Salmonella enterica isolates of non-Typhimurium serotypes. Int J Med Microbiol2013; 303: 25–31.
14.
QuinoWHurtadoCVEscalante-MaldonadoO, et al.Multidrogorresistencia de Salmonella Infantis en Perú: un estudio mediante secuenciamiento de nueva generación. Rev Peru Med Exp Salud Publica2019; 36: 37–45.
15.
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Document M100 - S19. Wayne: CLSI, 2009.
16.
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Document M100 - S19. Wayne: CLSI, 2010.
17.
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Document M100 - S19. Wayne: CLSI, 2012.
18.
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Document M100 - S19. Wayne: CLSI, 2013.
19.
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Document M100 - S19. Wayne: CLSI, 2014.
20.
MagiorakosAPSrinivasanACareyRB, et al.Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect2012; 18: 268–281.
21.
HornaGAmaroCPalaciosA, et al.High frequency of the exoU + /exoS + genotype associated with multidrug-resistant “high-risk clones” of Pseudomonas aeruginosa clinical isolates from Peruvian hospitals. Sci Rep2019; 9: 10874.
22.
Gonzales-EscalanteE. Incremento de aislamientos de Salmonella spp. productora de β-lactamasas de espectro extendido en pacientes pediátricos del Instituto Nacional de Salud del Niño. Rev Peru Med Exp Salud Publica2015; 32: 605–607.
23.
Cartelle GestalMZuritaJPaz y MinoA, et al.Characterization of a small outbreak of Salmonella enterica serovar Infantis that harbour CTX-M-65 in Ecuador. Braz J Infect Dis2016; 20: 406–407.
24.
LapierreLCornejoJZavalaS, et al.Phenotypic and genotypic characterization of virulence factors and susceptibility to antibiotics in Salmonella Infantis strains isolated from chicken meat: first findings in Chile. Animals (Basel)2020; 10: 1049.
25.
BlahováJLesická-HupkováMKrálikováK, et al.ended-spectrum β-lactamase-producing Salmonella enteritidis. J Chemother1998; 10: 291–294.
26.
CoipanCEWestrellTvan HoekAHAM, et al.Genomic epidemiology of emerging ESBL-producing Salmonella Kentucky blaCTX−M−14b in Europe. Emerg Microbes Infect2020; 9: 2124–2135.
27.
HindermannDGopinathGChaseH, et al.Salmonella enterica serovar Infantis from food and human infections, Switzerland, 2010–2015: poultry-related multidrug resistant clones and an emerging ESBL producing clonal lineage. Front Microbiol.2017; 8: 1322.
28.
TysonGHLiCHarrisonLB, et al.A multidrug-resistant Salmonella Infantis clone is spreading and recombining in the United States. Microb Drug Resist2021; 27: 792–799. https://doi.org/10.1089/mdr2020.0389.
29.
GarcíaCLejonVHornaG, et al.Intermediate susceptibility to ciprofloxacin among Salmonella enterica serovar Typhi isolates in Lima, Peru. J Clin Microbiol2014; 52: 968–970.
30.
Martínez-PucholSGomesCPonsMJ, et al.Development and analysis of furazolidone-resistant Escherichia coli mutants. APMIS2015; 123: 676–681.
